Cargando…

Calprotectin: from biomarker to biological function

The incidence of inflammatory bowel diseases (IBD) emerged with Westernisation of dietary habits worldwide. Crohn’s disease and ulcerative colitis are chronic debilitating conditions that afflict individuals with substantial morbidity and challenge healthcare systems across the globe. Since identifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jukic, Almina, Bakiri, Latifa, Wagner, Erwin F., Tilg, Herbert, Adolph, Timon E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Recent Advances in Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458070/ https://www.ncbi.nlm.nih.gov/pubmed/34145045 http://dx.doi.org/10.1136/gutjnl-2021-324855

Ejemplares similares

Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts
por: Adolph, Timon E, et al.
Publicado: (2022)

Gut microbiome and health: mechanistic insights
por: de Vos, Willem M, et al.
Publicado: (2022)

Epigenetics in liver disease: from biology to therapeutics
por: Hardy, Timothy, et al.
Publicado: (2016)

Liver sampling: a vital window into HBV pathogenesis on the path to functional cure
por: Gill, Upkar S, et al.
Publicado: (2018)

Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases
por: Zollner, Andreas, et al.
Publicado: (2022)

Niche-specific functional heterogeneity of intestinal resident macrophages
por: Viola, Maria Francesca, et al.
Publicado: (2021)

Organoids in gastrointestinal diseases: from experimental models to clinical translation
por: Günther, Claudia, et al.
Publicado: (2022)

The gut microbiota and host health: a new clinical frontier
por: Marchesi, Julian R, et al.
Publicado: (2016)

Liver organoids: from basic research to therapeutic applications
por: Prior, Nicole, et al.
Publicado: (2019)

Microbial transmission, colonisation and succession: from pregnancy to infancy
por: Xiao, Liwen, et al.
Publicado: (2023)

From the origin of NASH to the future of metabolic fatty liver disease
por: Geier, Andreas, et al.
Publicado: (2021)

COVID-19 and immunomodulation in IBD
por: Neurath, Markus F
Publicado: (2020)

MicroRNAs: new players in IBD
por: Kalla, R, et al.
Publicado: (2015)

Interferon lambdas: the next cytokine storm
por: Kelly, Christabel, et al.
Publicado: (2011)

Gene expression and hepatitis C virus infection
por: Asselah, T, et al.
Publicado: (2009)

The vagal innervation of the gut and immune homeostasis
por: Matteoli, Gianluca, et al.
Publicado: (2013)

Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
por: Hessmann, Elisabeth, et al.
Publicado: (2017)

Human gut microbiome: hopes, threats and promises
por: Cani, Patrice D
Publicado: (2018)

Role of the microbiome in human development
por: Dominguez-Bello, Maria Gloria, et al.
Publicado: (2019)

Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine
por: Conway, James RW, et al.
Publicado: (2019)

Protease inhibition as new therapeutic strategy for GI diseases
por: Vergnolle, Nathalie
Publicado: (2016)

Interaction between drugs and the gut microbiome
por: Weersma, Rinse K, et al.
Publicado: (2020)

The role of gut microbiota in cancer treatment: friend or foe?
por: Cheng, Wing Yin, et al.
Publicado: (2020)

Mucus barrier, mucins and gut microbiota: the expected slimy partners?
por: Paone, Paola, et al.
Publicado: (2020)

Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells
por: Powell, Nick, et al.
Publicado: (2020)

Regulatory T-cell therapy in Crohn’s disease: challenges and advances
por: Clough, Jennie N, et al.
Publicado: (2020)

Gut microbiota-derived metabolites as central regulators in metabolic disorders
por: Agus, Allison, et al.
Publicado: (2021)

Dietary macronutrients and the gut microbiome: a precision nutrition approach to improve cardiometabolic health
por: Jardon, Kelly M, et al.
Publicado: (2022)

Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
por: Ting, Nick Lung-Ngai, et al.
Publicado: (2022)

Immunopathogenesis and environmental triggers in coeliac disease
por: Levescot, Anais, et al.
Publicado: (2022)

Advancing human gut microbiota research by considering gut transit time
por: Procházková, Nicola, et al.
Publicado: (2023)

Faecal calprotectin indicates intestinal inflammation in COVID-19
por: Effenberger, Maria, et al.
Publicado: (2020)

Severe acute respiratory syndrome (SARS) in children: epidemiology, presentation and management
por: Leung, T.F, et al.
Publicado: (2003)

Current therapies and new developments in NASH
por: Dufour, Jean-François, et al.
Publicado: (2022)

Applications of dual energy CT in clinical practice: A pictorial essay
por: Sanghavi, Parang S, et al.
Publicado: (2019)

MR-guided focused ultrasound surgery: A novel non-invasive technique in the treatment of adenomyosis –18 month's follow-up of 12 cases
por: Dev, Bhawna, et al.
Publicado: (2019)

Mechanisms of rhinovirus-induced asthma
por: Papadopoulos, Nikolaos G, et al.
Publicado: (2004)

News and views on EMT Fra-1 controls EMT in mammary epithelial cells
por: Bakiri, Latifa, et al.
Publicado: (2015)

24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγ
por: Grander, Christoph, et al.
Publicado: (2023)

Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade
por: Tilg, Herbert, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8c970it21r04u1a1ju0i43cb3o